Outstanding Achievement in Clinical Diabetes Research Award

Award Profile: 

This award was established in 2015 to recognize individuals for outstanding contributions in patient-oriented clinical outcomes research that has significant impact on diabetes prevention and treatment.   

Criteria for Selection (candidates can be peer or self-nominated): 

  • The nominee’s research must be patient-oriented, including clinical trials and outcomes research involving human subjects. 
  • The nominee is well-known nationally or internationally for exceptional clinical research knowledge and expertise.
  • The nominee has outstanding track record of sharing their expertise with other health care professionals as documented by presentations and/or authorship of books/articles/reference materials. 
  • The nominee can represent any type of diabetes clinical professional.
  • The nominee is a current member of the Professional Section of the American Diabetes Association® (ADA).
  • Both U.S. and non-U.S. residents are eligible for award.
  • Contributions and volunteer service to both national and international diabetes organizations and the broader diabetes community may also be taken into consideration.   


  • There is no lecture associated with this award.


  • The recipient receives a $3,000 honorarium.
  • The award includes two round-trip coach airfares and hotel accommodations for the duration of the Scientific Sessions.
  • The award includes complimentary registration to the 85th Scientific Sessions in Chicago, IL, taking place June 20–23, 2025. 

2025 Nomination/Submission Process:

  • Nominations must be submitted using the new electronic nomination form. All submissions must be received on or before 8:00 p.m. ET on September 20, 2024.
  • Nominations are accepted from any ADA professional member.

    All Clinical Research in Diabetes Awards nominations must have the following documents uploaded as one PDF file:

    • A letter of nomination/support, whether peer or self-nominated, must be no more than 400 words and signed by no more than three individuals. 
    • The nomination letter/support should address criteria for selection (above), the most significant clinical research accomplishments of the nominee, and the impact of these accomplishments on clinical practice/patient care and outcomes.
    • The nominee’s CV with career and publication highlights. 

      Questions? Email Gedeon Topacio, program manager of research & scientific programs, at


The recipient is chosen by the National Scientific & Health Care Achievement Awards Committee and approved by the ADA’s Executive Committee in February 2025.

2024 Outstanding Achievement in Clinical Diabetes Research Award

Samuel Dagogo-Jack, MD, DSc

Previous Outstanding Achievement in Clinical Diabetes Research Award Recipients

2018 Rury R. Holman, FRCP, FMedSci
2017 William V. Tamborlane, MD
2016 Steven E. Kahn, MB, ChB
2015 David M. Nathan, MD